Cargando…

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas

The epithelial-mesenchymal transition (EMT) is an important process that drives progression, metastasis, and oncology treatment resistance in cancers. Also, the adjacent non-tumor tissue may affect the biological properties of cancers and have potential prognostic implications. Our study aimed to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jiasheng, He, Jinru, Zhang, Jiheng, Ji, Hang, Wang, Nan, Ma, Shuai, Yan, Xiuwei, Gao, Xin, Du, Jianyang, Liu, Zhihui, Hu, Shaoshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152435/ https://www.ncbi.nlm.nih.gov/pubmed/35656554 http://dx.doi.org/10.3389/fcell.2022.887693

Ejemplares similares

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
por: Wang, Nan, et al.
Publicado: (2022)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma
por: Liu, Zhihui, et al.
Publicado: (2022)

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism
por: Liu, Zhihui, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

Metabolism-Associated DNA Methylation Signature Stratifies Lower-Grade Glioma Patients and Predicts Response to Immunotherapy
por: Yang, Guozheng, et al.
Publicado: (2022)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021)

Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma
por: Zhao, Hongtao, et al.
Publicado: (2023)

Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas
por: Chen, Zhimin, et al.
Publicado: (2021)

Using mixed reality technique combines multimodal imaging signatures to adjuvant glioma photodynamic therapy
por: Dong, Jiawei, et al.
Publicado: (2023)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
por: Li, Ganglei, et al.
Publicado: (2021)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Glycosylation modification patterns reveal distinct tumor metabolism and immune microenvironment landscape in lower-grade gliomas
por: Tang, Guihua, et al.
Publicado: (2022)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas
por: Ji, Hang, et al.
Publicado: (2022)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
por: Mo, Shaobo, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
por: Liu, Han-jie, et al.
Publicado: (2020)

A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
por: Yan, Yilin, et al.
Publicado: (2021)

Differential and Prognostic Significance of HOXB7 in Gliomas
por: Zhou, Xingang, et al.
Publicado: (2021)

Long Non-Coding RNA SNHG6 Supports Glioma Progression Through Upregulation of Notch1, Sox2, and EMT
por: Nie, Jing, et al.
Publicado: (2021)

Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade glioma
por: Karandikar, Paramesh V., et al.
Publicado: (2023)

New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Zhou, Liwei, et al.
Publicado: (2021)

A Calcium-Related Immune Signature in Prognosis Prediction of Patients With Glioma
por: Lin, Cha, et al.
Publicado: (2021)

Pituitary adenoma secondary to primary hypothyroidism: Two case reports
por: Du, Jianyang, et al.
Publicado: (2020)

Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas
por: Liu, Wangrui, et al.
Publicado: (2021)

Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas
por: Zhang, Jingwei, et al.
Publicado: (2022)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

A Prognostic Model for Colon Cancer Patients Based on Eight Signature Autophagy Genes
por: Xu, Jiasheng, et al.
Publicado: (2020)

Comprehensive Analysis of the Clinical and Biological Significances of Endoplasmic Reticulum Stress in Diffuse Gliomas
por: Huang, Ruoyu, et al.
Publicado: (2021)

Hypermethylation of LATS2 Promoter and Its Prognostic Value in IDH-Mutated Low-Grade Gliomas
por: Gu, Yuan, et al.
Publicado: (2020)

CircGLIS3 Promotes High-Grade Glioma Invasion via Modulating Ezrin Phosphorylation
por: Li, Yan, et al.
Publicado: (2021)

Epigenetic programming of pediatric high-grade glioma: Pushing beyond proof of concept to clinical benefit
por: Groves, Andrew, et al.
Publicado: (2022)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m5cjapkqgulootvvlou0sv32ir